Genetic Mutation

Diagnostics company launches cystic fibrosis test

Published in Gene Therapy Weekly, October 30th, 2003

Tm Bioscience Corporation announced the launch of the 40-mutation Tag-It Mutation Detection Kit for Cystic Fibrosis (CF40).

Cystic fibrosis (CF) carrier screening is currently the world's largest and fastest growing human genetic test market.

"The Tag-It CF40 Mutation Detection Kit, with an industry leading ability to identify the 40 most common genetic mutations in the CF gene, combines broad mutation coverage with unmatched speed, accuracy and cost," said Greg Hines, president and chief executive officer of Tm Bioscience.

"We expect the CF40 test to be our flagship product for the next several years as this market continues to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2003-10-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry